Invenia ABUS Premium

Invenia™ ABUS Premium provides the most innovative, patient-friendly, efficient and AI-driven 3D breast ultrasound designed to deliver optimal outcomes.

Invenia ABUS Premium

    At a glance

    Impactful screening solution

    Improve breast cancer detection by 35.7% over mammography alone in dense breasts¹

    Productivity powered by AI

    Boost clinical confidence and efficiency with AI-driven scanning and reading

    Outstanding patient comfort

    Explore a non-invasive and patient-friendly breast ultrasound experience

    Invenia ABUS Premium: an innovative AI-driven 3D ultrasound solution for patients with dense breasts

    Invenia ABUS is the first FDA-approved supplemental ultrasound screening technology that is specifically designed for detecting cancer in dense breast tissue. Embrace the new era of breast ultrasound with our comprehensive, non-invasive, patient-friendly solution for screening and beyond.
    Download the brochure
    The facts

    Why breast density matters

    Dense breast tissue and cancer appear white on a mammogram, potentially camouflaging small cancers, and in fact, up to 50% of breast cancers may be missed in extremely dense breasts.⁴

    Features

    The latest innovation in breast ultrasound

    The Invenia ABUS Premium is designed for high patient throughput and extraordinary image quality to provide a great level of confidence. With its innovative design, it’s easy to use, reproducible, user-independent, standardized and allows reading anywhere.

    Verisound™ AI-powered solutions enhance confidence and speed workflow

    • Scan Quality Assessment provides an immediate, qualitative evaluation for proper breast coverage and positioning.
    • Auto Nipple Detection automatically offers nipple marker positioning to enable consistency and speed exams.

    The novel Reverse Curve™ transducer is designed for enhanced performance

    Its gentle 15.3 cm shape follows the breast's natural contour, enhancing patient comfort* and ensuring full contact for comprehensive coverage. The improved image quality* increases diagnostic confidence for reading ABUS exams.

    Excellent image quality and 40% faster scan speed

    • cSound Imageformer, software-based processing, produces exquisite, reproducible images by leveraging automatic focus at every pixel.
    • Fast Scan increases scan speed by 40%*, fostering improved efficiency and patient throughput.

    Centralized reading everywhere with the Invenia ABUS Viewer with AI Assistant

    Invenia ABUS Viewer’s efficient workflow, with AI Assistant**, allows physicians to quickly review, interpret, and archive exams, even remotely.
    • Experience up to 93%⁵ sensitivity for lesion detection and reduce reading time by 33% with QVCAD™⁶
    • Decrease benign biopsies by up to 55% with Koios DS™ Breast⁷

    The Breast Care Pathway

    Invenia ABUS is an important pillar in the comprehensive Breast Care Pathway

    Screening

    Exact lesion localization and double reading capability empower ABUS in early detection

    Diagnostic

    Virtual rescans and multiplanar readings of the entire breast support case management

    Planning

    Offers a 3D view of the entire breast for precise and effective therapy planning

    Monitoring

    Compare reproducible ABUS volumes to priors to help monitor therapy response
    Mobility improves access

    Bring the power of ABUS to your patients

    The Mobile Invenia™ ABUS solutions let you bring extraordinary patient care to more places with the Mobile ABUS Fixation Bracket***. With 100% of women recommending ABUS to their best friend⁹, why not bring it directly to patients everywhere?

    Watch video
    Disclaimers
    *Compared to Invenia ABUS 2.0.

    **AI Assistant third-party AI tools powered by QVCAD and Koios DS Breast.

    ***The Invenia ABUS device is not designed for use in a mobile environment unless it is installed using the Mobile ABUS fixation system.
    References
    1. FDA PMA P110006 summary of safety and effectiveness.
    2. Pisano et al. NEJM 2005; 353: 1773.
    3. Engmann NJ, et al, JAMA Oncol. 2017;3(9):1228-1236.
    4. Kolb et al, Radiology, Oct 2002;225(1):165-75.
    5. Performance and Reading Time of Automated Breast US with or without Computer-aided Detection. Read More: https://pubs.rsna.org/doi/10.1148/radiol.2019181816.
    6. Interpretation Time Using a Concurrent-Read Computer-Aided Detection System for Automated Breast Ultrasound in Breast Cancer Screening of Women With Dense Breast Tissue (Yulei Jiang) Read More: https://www.ajronline.org/doi/10.2214/AJR.18.19516.
    7. Barinov, et al. Impact of Data Presentation on Physician Performance Utilizing Artificial Intelligence-Based Computer- Aided Diagnosis and Decision Support Systems. J Digit Imaging (2018). https://doi.org/10.1007/s10278-018-0132-5.
    8. Wenhui Ren et. al, Elsevier Acad Radiol 2023; 30:S114
    9. Shah et.al. Journal of Diagnostic Medical Sonography DOI: 10.1177/8756479313476920 2013.
    Get in touch

    Have a question? We would love to hear from you.

    JB02794XU